Versarien PLC Q&A to discuss Latest Interim Results (LON:VRS)
1 December 2017
For investors with an eye on the biotechnology sector, Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) presents a compelling opportunity, driven by its substantial potential upside of 94.89%. As a clinical-stage biopharmaceutical..
Quantum-Si Incorporated (NASDAQ: QSI) is making waves in the healthcare sector, particularly in the medical devices industry, with its innovative approach to protein sequencing technology. As a life sciences company..
Canopy Growth Corporation (NASDAQ: CGC), headquartered in Smiths Falls, Canada, continues to be a focal point for investors eyeing the burgeoning cannabis industry. As a major player in the healthcare..
Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering entity in the biopharmaceutical landscape, is capturing investor attention with its impressive potential upside of 236.80%. This clinical-stage biotech company, headquartered in Needham,..
Pacific Biosciences of California, Inc. (NASDAQ: PACB) stands out in the healthcare sector’s medical devices industry, particularly for its innovative solutions in the field of genetic sequencing. Headquartered in Menlo..
Exxon Mobil Corporation (NYSE: XOM), a behemoth in the energy sector with a market capitalization of $656.02 billion, continues to be a focal point for investors seeking stability in the..
Chevron Corporation (NYSE: CVX), a titan in the global energy sector, stands tall with a market capitalization of $371.52 billion. Known for its comprehensive operations in the oil and gas..
Aurora Cannabis Inc. (NYSE: ACB) continues to be a focal point for investors eyeing the burgeoning cannabis sector. With its diverse portfolio and international reach, Aurora offers a compelling narrative..
Spok Holdings, Inc. (NASDAQ: SPOK), a key player in the healthcare communication solutions sector, presents a unique blend of stability and opportunity for investors seeking exposure to the health information..
Alpha Teknova, Inc. (NASDAQ: TKNO) stands as a noteworthy player in the healthcare sector, specifically within the drug manufacturing industry, focusing on specialty and generic products. With a market capitalization..
Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector specializing in medical devices, presents an intriguing investment opportunity with a potential upside of 32.26%. The company, headquartered..
TruBridge, Inc. (NASDAQ: TBRG), a prominent player in the healthcare sector, operates within the health information services industry, providing critical solutions to enhance financial health and patient care for healthcare..
ClearPoint Neuro Inc. (NASDAQ: CLPT), a pioneering player in the healthcare sector’s medical devices industry, is capturing investor attention with its impressive potential upside of 116.90%. Specializing in minimally invasive..
Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company based in Singapore, is capturing the attention of investors with its innovative approach to RNA medicine. With a market capitalization..
The Pennant Group, Inc. (NASDAQ: PNTG) is emerging as a compelling opportunity for investors within the healthcare sector. With a robust market capitalization of $1.07 billion, this Idaho-based company operates..
Dynavax Technologies Corporation (NASDAQ: DVAX) is garnering attention in the healthcare sector, particularly among investors eyeing its promising potential upside. With a market capitalization of $1.82 billion, this biopharmaceutical company..
Harrow, Inc. (NASDAQ: HROW), a noteworthy entity in the healthcare sector, is capturing investor attention with a formidable 48.81% potential upside. Specializing in the development and commercialization of ophthalmic pharmaceutical..
In the dynamic world of biotechnology, Vera Therapeutics, Inc. (NASDAQ: VERA) emerges as a compelling player with significant upside potential. With a market capitalization of $3.11 billion, the California-based company..
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a key player in the healthcare sector, has attracted attention for its promising potential upside of 10.35%. Specializing in both generic and proprietary injectable, inhalation,..
